Authors:
Johannessen, LE
Haugen, KE
Ostvold, AC
Stang, E
Madshus, IH
Citation: Le. Johannessen et al., Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2and the affinity of EGF binding are regulated by different mechanisms, BIOCHEM J, 356, 2001, pp. 87-96
Authors:
Stang, E
Johannessen, LE
Knardal, SL
Madshus, IH
Citation: E. Stang et al., Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation, J BIOL CHEM, 275(18), 2000, pp. 13940-13947
Authors:
Johannessen, LE
Ringerike, T
Molnes, J
Madshus, IH
Citation: Le. Johannessen et al., Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis, EXP CELL RE, 260(1), 2000, pp. 136-145
Authors:
Lindeman, B
Skarpen, E
Thoresen, TH
Christoffersen, T
Wierod, L
Madshus, IH
Huitfeldt, HS
Citation: B. Lindeman et al., Alteration of G(1) cell-cycle protein expression and induction of p53 but not p21/waf1 by the DNA-modifying carcinogen 2-acetylaminofluorene in growth-stimulated hepatocytes in vitro, MOL CARCINO, 24(1), 1999, pp. 36-46
Citation: Le. Johannessen et al., Epidermal growth factor increases the level of the cyclin-dependent kinase(CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein, BIOCHEM J, 337, 1999, pp. 599-606
Citation: Hk. Nogva et al., One-tube multiplex RT-PCR of BCR-ABL transcripts in analysis of patients with chronic myeloid leukaemia and acute lymphoblastic leukaemia, SC J CL INV, 58(8), 1998, pp. 647-654